Free public records show GT Metabolic Solutions, Inc. in 4 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by GT Metabolic Solutions, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
7 active studies led by GT Metabolic Solutions, Inc., of 14 in all
Source: ClinicalTrials.gov, Studies with GT Metabolic Solutions, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
4 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies GT Metabolic Solutions, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with GT Metabolic Solutions, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show GT Metabolic Solutions, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets GT Metabolic Solutions, Inc. is in.
Stories on the topics GT Metabolic Solutions, Inc. works in.
2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack…
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
ReadSearch all reports for GT Metabolic Solutions, Inc. All companies